Zobrazeno 1 - 10
of 123
pro vyhledávání: '"Aljoscha S Neubauer"'
Autor:
Lukas Reznicek, Carmen Stumpf, Florian Seidensticker, Anselm Kampik, Aljoscha S Neubauer, Marcus Kernt
Publikováno v:
International Journal of Ophthalmology, Vol 7, Iss 4, Pp 697-703 (2014)
AIM:To evaluate the diagnostic properties of wide-field fundus autofluorescence (FAF) scanning laser ophthalmoscope (SLO) imaging for differentiating choroidal pigmented lesions.METHODS:A consecutive series of 139 patients were included, 101 had esta
Externí odkaz:
https://doaj.org/article/d31033ab078a4fd2b3ee2b1301f47f1b
Autor:
Rashid Al Saeidi, Marcus Kernt, Thomas C Kreutzer, Guenther Rudolph, Aljoscha S Neubauer, Christos Haritoglou
Publikováno v:
Oman Journal of Ophthalmology, Vol 6, Iss 4, Pp 36-39 (2013)
Purpose: To evaluate the efficacy of a computerized color vision testing (Arden color contrast test) as a screening test for detection of diabetic macular edema (DME). Materials and Methods: A consecutive, prospective case series of 83 eyes of 42 di
Externí odkaz:
https://doaj.org/article/a4c99c73c3e14aa6a903b3a30dc9a592
Publikováno v:
Clinical Ophthalmology, Vol 2010, Iss default, Pp 591-604 (2010)
Marcus Kernt, Aljoscha S Neubauer, Kirsten H Eibl, Armin Wolf, Michael W Ulbig, Anselm Kampik, Cristoph HirneissDepartment of Ophthalmology, Ludwig-Maximilians-University, Munich, GermanyIntroduction: Primary open-angle glaucoma (POAG) is one of the
Externí odkaz:
https://doaj.org/article/4d42bb2761d94fe58dad9e4dc1837e0c
Autor:
Raffael Liegl, Julian Langer, Florian Seidensticker, Lukas Reznicek, Christos Haritoglou, Michael W Ulbig, Aljoscha S Neubauer, Anselm Kampik, Marcus Kernt
Publikováno v:
PLoS ONE, Vol 9, Iss 12, p e113981 (2014)
OBJECTIVE: To evaluate if a standardized combination therapy regimen, utilizing 3 monthly ranibizumab injections followed by navigated laser photocoagulation, reduces the number of total ranibizumab injections required for treatment of diabetic macul
Externí odkaz:
https://doaj.org/article/b63f0047fa6241b2b395fd4a4fa6a698
Publikováno v:
Gesundheitsökonomie & Qualitätsmanagement. 27:25-35
Zusammenfassung Zielsetzung Die ökonomischen Unterschiede von Arzneimitteln für neuartige Therapien (ATMP) gegenüber chronischen Therapien sollen charakterisiert und am Beispiel der seltenen neuropädiatrischen Erkrankung AADC-Mangel veranschaulic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::681dfe61b6946f24692eac29b02aab47
https://doi.org/10.1055/a-1629-7213
https://doi.org/10.1055/a-1629-7213
Publikováno v:
Clinical Ophthalmology (Auckland, N.Z.)
Menzler, J, Neubauer, A S, Haritoglou, C & Jackson, T L 2019, ' Incidence and prevalence of vitreomacular traction with and without macular hole in Germany ', Clinical ophthalmology (Auckland, N.Z.), vol. 13, pp. 177-188 . https://doi.org/10.2147/OPTH.S188704
Menzler, J, Neubauer, A S, Haritoglou, C & Jackson, T L 2019, ' Incidence and prevalence of vitreomacular traction with and without macular hole in Germany ', Clinical ophthalmology (Auckland, N.Z.), vol. 13, pp. 177-188 . https://doi.org/10.2147/OPTH.S188704
Jacob Menzler,1 Aljoscha Steffen Neubauer,1,2 Christos Haritoglou,3 Timothy L Jackson4 1Institute for Health- and Pharmacoeconomics/Neubauer Consult, Munich, Germany; 2Private practice, Munich, Germany; 3Herzog Carl Theodor Eye Hospital, Munich, Germ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a15f25a72e74c8fc7af8b4bb78c6bce0
http://europepmc.org/articles/PMC6339449
http://europepmc.org/articles/PMC6339449
Publikováno v:
Expert opinion on pharmacotherapy. 21(4)
Introduction: Diabetic macular edema (DME) is a sight threatening disease and a major cause for blindness for people in working age. The pathogenesis is multifactorial and complex. The pharmacotherapy of DME addresses both the inhibition of vascular
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51d04cfbb761f859e9380dc33a612ab4
https://pubmed.ncbi.nlm.nih.gov/31957495
https://pubmed.ncbi.nlm.nih.gov/31957495
Publikováno v:
Klinische Monatsblätter für Augenheilkunde. 236:180-191
Zusammenfassung Hintergrund Bei der Behandlung eines diabetischen Makulaödems mit fovealer Beteiligung kann es trotz intensiver und konsequenter initialer Therapie mit einem Anti-VEGF-Medikament zu einem unzureichenden Ansprechen kommen. Für eine w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::db3b83fae279fb1b678146a400169109
https://doi.org/10.1055/s-0043-125076
https://doi.org/10.1055/s-0043-125076
Autor:
Salvatore Grisanti, Maximilian Kurz, Annekatrin Holzhey, Mahdy Ranjbar, Aljoscha S. Neubauer, Martin Rudolf
Publikováno v:
Klinische Monatsblätter für Augenheilkunde. 236:892-900
Zusammenfassung Hintergrund Die stereotaktische Radiotherapie (SRT) ist ein neues adjuvantes Verfahren zu den bisherigen intravitrealen operativen Medikamentengaben (IVOM) bei exsudativer altersbedingter Makuladegeneration (AMD). Ziel unserer Studie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bd5e3d2550afa23ceb9e39208766668d
https://doi.org/10.1055/s-0043-115903
https://doi.org/10.1055/s-0043-115903
Publikováno v:
International Journal of Ophthalmology, Vol 12, Iss 2, Pp 342-345 (2019)
We inquired the impact of reduced therapy discontinuation in diabetic macular edema (DME) on physician’s revenue considering anti-vascular endothelial growth factor (VEGF) monotherapy and its combination with Navilas treatment. Data were collected
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f9250adccb2392fe6cc2587883205f1
https://doi.org/10.18240/ijo.2019.02.24
https://doi.org/10.18240/ijo.2019.02.24